Junji Kobayashi

4.8k total citations
158 papers, 3.7k citations indexed

About

Junji Kobayashi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Junji Kobayashi has authored 158 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Endocrinology, Diabetes and Metabolism, 74 papers in Surgery and 60 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Junji Kobayashi's work include Diabetes, Cardiovascular Risks, and Lipoproteins (70 papers), Lipoproteins and Cardiovascular Health (54 papers) and Lipid metabolism and disorders (46 papers). Junji Kobayashi is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (70 papers), Lipoproteins and Cardiovascular Health (54 papers) and Lipid metabolism and disorders (46 papers). Junji Kobayashi collaborates with scholars based in Japan, United States and Australia. Junji Kobayashi's co-authors include Hiroshi Mabuchi, Atsushi Nohara, Akihiro Inazu, Masa‐aki Kawashiri, Masakazu Yamagishi, Junji Koizumi, Katsuyuki Nakajima, Hideaki Bujo, Hayato Tada and Shoji Katsuda and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Junji Kobayashi

153 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junji Kobayashi Japan	35	1.6k	1.4k	1.3k	863	595	158	3.7k
Tjerk W.A. de Bruin Netherlands	42	2.2k 1.4×	1.6k 1.1×	1.2k 0.9×	1.1k 1.2×	623 1.0×	122	4.2k
Shui‐Ping Zhao China	35	1.0k 0.7×	1.5k 1.1×	1.2k 0.9×	1.0k 1.2×	722 1.2×	235	4.3k
Genovefa Kolovou Greece	34	1.4k 0.9×	1.4k 0.9×	1.8k 1.4×	681 0.8×	793 1.3×	247	4.6k
John R. Burnett Australia	36	1.3k 0.8×	2.5k 1.7×	956 0.7×	1.3k 1.5×	443 0.7×	164	4.6k
Mikko Syvänne Finland	32	1.4k 0.9×	1.6k 1.1×	1.6k 1.2×	982 1.1×	387 0.7×	71	4.0k
Robin P.F. Dullaart Netherlands	40	2.3k 1.5×	1.6k 1.1×	728 0.6×	1.0k 1.2×	1.1k 1.8×	188	4.8k
Jean Dallongeville France	20	896 0.6×	1.0k 0.7×	906 0.7×	999 1.2×	518 0.9×	47	3.2k
E. Windler Germany	25	1.3k 0.8×	1.2k 0.8×	569 0.4×	807 0.9×	506 0.9×	82	3.1k
Bryan Brewer United States	15	1.6k 1.0×	2.0k 1.4×	787 0.6×	1.3k 1.4×	736 1.2×	19	4.1k
Shizuya Yamashita Japan	35	1.2k 0.7×	1.4k 1.0×	822 0.6×	1.4k 1.7×	633 1.1×	97	3.6k

Countries citing papers authored by Junji Kobayashi

Since Specialization

Citations

This map shows the geographic impact of Junji Kobayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junji Kobayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junji Kobayashi more than expected).

Fields of papers citing papers by Junji Kobayashi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junji Kobayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junji Kobayashi. The network helps show where Junji Kobayashi may publish in the future.

Co-authorship network of co-authors of Junji Kobayashi

This figure shows the co-authorship network connecting the top 25 collaborators of Junji Kobayashi. A scholar is included among the top collaborators of Junji Kobayashi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junji Kobayashi. Junji Kobayashi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kobayashi, Junji, et al.. (2024). Familial hypercholesterolemia with special focus on Japan. Clinica Chimica Acta. 556. 117847–117847.

Nakajima, Kiyomi, Tetsuo Machida, Shigeyuki Imamura, et al.. (2018). An automated method for measuring lipoprotein lipase and hepatic triglyceride lipase activities in post-heparin plasma. Clinica Chimica Acta. 487. 54–59. 7 indexed citations

Moriya, Junji, et al.. (2015). Induction Murine Models of Chronic Fatigue Syndrome byBrucella abortusAntigen Injections: Is Anemia Induced or Not?. BioMed Research International. 2015. 1–4. 3 indexed citations

Mabuchi, Hiroshi, Atsushi Nohara, Tohru Noguchi, et al.. (2014). Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation. Atherosclerosis. 236(1). 54–61. 64 indexed citations

Shirakawa, Takashi, Katsuyuki Nakajima, Younosuke Shimomura, et al.. (2014). Comparison of the effect of post-heparin and pre-heparin lipoprotein lipase and hepatic triglyceride lipase on remnant lipoprotein metabolism. Clinica Chimica Acta. 440. 193–200. 23 indexed citations

Moriya, Junji, Kenji Takeuchi, Yoshiharu Motoo, et al.. (2014). Successful Treatment of Post-influenza Chronic Fatigue Syndrome with Kampo Medicine : a Case Report. Kampo Medicine. 65(2). 87–93. 1 indexed citations

Yamakawa, Jun-ichi, Yoshiharu Motoo, Junji Moriya, et al.. (2013). Significance of Kampo, Traditional Japanese Medicine, in Supportive Care of Cancer Patients. Evidence-based Complementary and Alternative Medicine. 2013. 1–10. 16 indexed citations

Yamakawa, Jun-ichi, et al.. (2013). Significance of Kampo, Japanese Traditional Medicine, in the Treatment of Obesity: Basic and Clinical Evidence. Evidence-based Complementary and Alternative Medicine. 2013. 1–8. 14 indexed citations

Yagi, Kunimasa, Junji Kobayashi, Atsushi Nohara, et al.. (2013). Impact of Serum Retinol-Binding Protein 4 Levels on Regulation of Remnant-Like Particles Triglyceride in Type 2 Diabetes Mellitus. Journal of Diabetes Research. 2013. 1–5. 8 indexed citations

10.

Kakuda, Hirokazu, et al.. (2013). Short-Term Effect of Pitavastatin Treatment on Glucose and Lipid Metabolism and Oxidative Stress in Fasting and Postprandial State Using a Test Meal in Japanese Men. PubMed. 2013. 1–7. 12 indexed citations

11.

Inazu, Akihiro, Yoshihiro Noji, Takanobu WAKASUGI, et al.. (2011). Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects. Clinica Chimica Acta. 413(5-6). 537–543. 12 indexed citations

12.

Oka, Rie, Junji Kobayashi, Katsuyuki Miura, et al.. (2009). Difference between Fasting and Nonfasting Triglyceridemia; the Influence of Waist Circumference. Journal of Atherosclerosis and Thrombosis. 16(5). 633–640. 16 indexed citations

13.

Murase, Yuko, Junji Kobayashi, Atsushi Nohara, et al.. (2006). Raloxifene promotes adipocyte differentiation of 3T3-L1 cells. European Journal of Pharmacology. 538(1-3). 1–4. 23 indexed citations

14.

Imamura, Shigeyuki, Junji Kobayashi, Shin‐ichi Sakasegawa, et al.. (2006). A novel method for measuring human hepatic lipase activity in postheparin plasma. Journal of Lipid Research. 48(2). 453–457. 9 indexed citations

15.

Mabuchi, Hiroshi, Toshinori Higashikata, Masa‐aki Kawashiri, et al.. (2005). Reduction of Serum Ubiquinol-10 and Ubiquinone-10 Levels by Atorvastatin in Hypercholesterolemic Patients. Journal of Atherosclerosis and Thrombosis. 12(2). 111–119. 97 indexed citations

16.

Kobayashi, Junji, Shunichi Murano, Koutaro Yokote, et al.. (2000). Marked decrease in plasma apolipoprotein A-I and high density lipoprotein-cholesterol in a case with Werner syndrome. Clinica Chimica Acta. 293(1-2). 63–73. 5 indexed citations

17.

Kobayashi, Junji, Hidekuni Inadera, Yuki Fujita, et al.. (1994). A Naturally Occurring Mutation at the Second Base of Codon Asparagine 43 in the Proposed N-Linked Glycosylation Site of Human Lipoprotein Lipase: In Vivo Evidence That Asparagine 43 Is Essential for Catalysis and Secretion. Biochemical and Biophysical Research Communications. 205(1). 506–515. 11 indexed citations

18.

Inadera, Hidekuni, et al.. (1993). A Missense Mutation (Trp26→Arg) in Exon 3 of the Apolipoprotein CII Gene in a Patient with Apolipoprotein CII Deficiency (Apo CII-Wakayama). Biochemical and Biophysical Research Communications. 193(3). 1174–1183. 20 indexed citations

19.

Kobayashi, Junji, et al.. (1993). Lipoprotein lipase mass and activity in severe hypertriglyceridemia. Clinica Chimica Acta. 216(1-2). 113–123. 115 indexed citations

20.

Ameis, Detlev, Junji Kobayashi, R.C. Davis, et al.. (1991). Familial chylomicronemia (type I hyperlipoproteinemia) due to a single missense mutation in the lipoprotein lipase gene.. Journal of Clinical Investigation. 87(4). 1165–1170. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact